Public Employees Retirement Association of Colorado’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,921
Closed -$21K 1906
2024
Q4
$21K Hold
9,921
﹤0.01% 1901
2024
Q3
$28K Buy
9,921
+481
+5% +$1.28K ﹤0.01% 1904
2024
Q2
$22K Hold
9,440
﹤0.01% 1906
2024
Q1
$42K Hold
9,440
﹤0.01% 1850
2023
Q4
$30K Hold
9,440
﹤0.01% 1889
2023
Q3
$30K Hold
9,440
﹤0.01% 1889
2023
Q2
$47K Hold
9,440
﹤0.01% 1890
2023
Q1
$47K Hold
9,440
﹤0.01% 1899
2022
Q4
$59K Hold
9,440
﹤0.01% 1882
2022
Q3
$102K Hold
9,440
﹤0.01% 1797
2022
Q2
$108K Hold
9,440
﹤0.01% 1811
2022
Q1
$86K Hold
9,440
﹤0.01% 1864
2021
Q4
$141K Hold
9,440
﹤0.01% 1816
2021
Q3
$243K Hold
9,440
﹤0.01% 1642
2021
Q2
$246K Hold
9,440
﹤0.01% 1664
2021
Q1
$333K Hold
9,440
﹤0.01% 1482
2020
Q4
$238K Hold
9,440
﹤0.01% 1572
2020
Q3
$356K Hold
9,440
﹤0.01% 1162
2020
Q2
$404K Buy
+9,440
New +$341K ﹤0.01% 1083

Other funds holding ALLO

Public Employees Retirement Association of Colorado's ALLO Position: Q1 2025 in Review

Public Employees Retirement Association of Colorado sold out of Allogene Therapeutics (ALLO) in Q1 2025, closing a stake of 9,921 shares — an estimated $21K sold.

Public Employees Retirement Association of Colorado first reported a position in ALLO in Q2 2020 and held it in 19 quarters. The position peaked at $404K in Q2 2020. 170 funds tracked by Wall St. Rank hold ALLO as of Q1 2025.

  • Public Employees Retirement Association of Colorado reported no remaining Allogene Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Public Employees Retirement Association of Colorado sold 9,921 Allogene Therapeutics shares in Q1 2025, an estimated $21K.
  • Public Employees Retirement Association of Colorado first reported a position in Allogene Therapeutics in Q2 2020 and held it in 19 quarters.
  • Public Employees Retirement Association of Colorado's Allogene Therapeutics position peaked at $404K in Q2 2020.
  • 170 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q1 2025.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q1 2025, filed 12 May 2025.